NO890174L - RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES. - Google Patents
RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES.Info
- Publication number
- NO890174L NO890174L NO89890174A NO890174A NO890174L NO 890174 L NO890174 L NO 890174L NO 89890174 A NO89890174 A NO 89890174A NO 890174 A NO890174 A NO 890174A NO 890174 L NO890174 L NO 890174L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- 1alfa
- dna sequences
- recombinant interleukin
- recombinant vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Homogene rekombinante huaane intarleukin-lo polypep- tider, DNA-sekvenser som koder for slike polypeptider, rekonbinante vektorer inneholdende DNA-sekvenser, én- cellede vertsorganismer inneholdende slike rekonbinante vektorer, samt fremgangsmåter for fremstilling av polypeptidene. De humane interleukin-loc polypeptider og farmasøytiske blandinger inneholdende disse kan bli brukt for a stimulere immunsystemet hos en vert for å fremme sårleging og for a forbedre legingen av kritisk syke protein-undererruerte pasienter.Homogeneous recombinant human intarleukinol polypeptides, DNA sequences encoding such polypeptides, recombinant vectors containing DNA sequences, single-cell host organisms containing such recombinant vectors, and methods for producing the polypeptides. The human interleukin-loc polypeptides and pharmaceutical compositions containing them may be used to stimulate a host's immune system to promote wound healing and to improve the healing of critically ill protein-disrupted patients.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14445788A | 1988-01-15 | 1988-01-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO890174D0 NO890174D0 (en) | 1989-01-13 |
| NO890174L true NO890174L (en) | 1989-07-17 |
Family
ID=22508674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89890174A NO890174L (en) | 1988-01-15 | 1989-01-13 | RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0324447B1 (en) |
| JP (1) | JP2567079B2 (en) |
| AR (1) | AR245958A1 (en) |
| AT (1) | ATE142696T1 (en) |
| AU (1) | AU616461B2 (en) |
| DE (1) | DE58909723D1 (en) |
| DK (1) | DK16489A (en) |
| ES (1) | ES2091752T3 (en) |
| FI (1) | FI890175A7 (en) |
| GR (1) | GR3021887T3 (en) |
| HU (1) | HU208996B (en) |
| IE (1) | IE890087L (en) |
| IL (1) | IL88934A (en) |
| MC (1) | MC2002A1 (en) |
| NO (1) | NO890174L (en) |
| NZ (1) | NZ227594A (en) |
| PT (1) | PT89438B (en) |
| YU (1) | YU6889A (en) |
| ZA (1) | ZA89202B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587605T2 (en) * | 1984-12-25 | 1994-03-17 | Dainippon Pharmaceutical Co | Interleukin-1 and its derivative. |
| DE3818660A1 (en) * | 1987-06-05 | 1988-12-15 | Colgate Palmolive Co | FREE-FLOWING, POWDERY DISHWASHING DETERGENT AND METHOD FOR PRODUCING THE SAME |
| KR960008010B1 (en) * | 1988-07-29 | 1996-06-19 | 오오쓰까세이야꾸 가부시끼가이샤 | IL-1Ñß DERIVATIVES AND MEDICAMENT FOR TREATING THROMBOCYTOPENIA |
| US7176179B1 (en) | 1997-05-30 | 2007-02-13 | The Regents Of The University Of California | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
| US6191269B1 (en) | 1997-05-30 | 2001-02-20 | The Regents Of The University Of California | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
| US20030154504A1 (en) | 1998-06-24 | 2003-08-14 | Farese Robert V. | Methods and compositions for modulating carbohydrate metabolism |
| DE10252634A1 (en) * | 2002-11-11 | 2004-05-27 | Umwelttechnik Georg Fritzmeier Gmbh & Co. | Purification of sewage or other substances laden with harmful organic matter and detergent or clarifying agent also useful laundry and cleaning surfaces involve introduction of photosensitizer releasing singlet oxygen when stimulated |
| EP2464330B1 (en) * | 2009-09-29 | 2016-03-23 | United Technologies UT AG | Oral care compositions containing human recombinant interleukin-1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587605T2 (en) * | 1984-12-25 | 1994-03-17 | Dainippon Pharmaceutical Co | Interleukin-1 and its derivative. |
| EP0200986B2 (en) * | 1985-04-25 | 1998-03-11 | F. Hoffmann-La Roche Ag | Recombinant human interleukin-1 |
| DE3515217A1 (en) * | 1985-04-26 | 1986-10-30 | Siemens AG, 1000 Berlin und 8000 München | DEVICE FOR MEASURING LOW MAGNETIC FIELDS |
| US5017692A (en) * | 1986-09-04 | 1991-05-21 | Schering Corporation | Truncated human interleukin-a alpha |
-
1989
- 1989-01-10 ZA ZA89202A patent/ZA89202B/en unknown
- 1989-01-11 HU HU8980A patent/HU208996B/en not_active IP Right Cessation
- 1989-01-11 ES ES89100402T patent/ES2091752T3/en not_active Expired - Lifetime
- 1989-01-11 DE DE58909723T patent/DE58909723D1/en not_active Expired - Fee Related
- 1989-01-11 AT AT89100402T patent/ATE142696T1/en not_active IP Right Cessation
- 1989-01-11 EP EP89100402A patent/EP0324447B1/en not_active Expired - Lifetime
- 1989-01-11 NZ NZ227594A patent/NZ227594A/en unknown
- 1989-01-12 MC MC892025A patent/MC2002A1/en unknown
- 1989-01-12 AR AR89312971A patent/AR245958A1/en active
- 1989-01-12 YU YU00068/89A patent/YU6889A/en unknown
- 1989-01-12 IL IL8893489A patent/IL88934A/en not_active IP Right Cessation
- 1989-01-13 DK DK016489A patent/DK16489A/en not_active Application Discontinuation
- 1989-01-13 NO NO89890174A patent/NO890174L/en unknown
- 1989-01-13 PT PT89438A patent/PT89438B/en not_active IP Right Cessation
- 1989-01-13 IE IE890087A patent/IE890087L/en unknown
- 1989-01-13 JP JP1005058A patent/JP2567079B2/en not_active Expired - Lifetime
- 1989-01-13 FI FI890175A patent/FI890175A7/en not_active IP Right Cessation
- 1989-01-13 AU AU28509/89A patent/AU616461B2/en not_active Ceased
-
1996
- 1996-12-04 GR GR960403302T patent/GR3021887T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI890175L (en) | 1989-07-16 |
| NZ227594A (en) | 1991-09-25 |
| EP0324447A2 (en) | 1989-07-19 |
| DK16489A (en) | 1989-07-16 |
| AU616461B2 (en) | 1991-10-31 |
| IL88934A (en) | 1994-05-30 |
| HUT50505A (en) | 1990-02-28 |
| EP0324447B1 (en) | 1996-09-11 |
| JP2567079B2 (en) | 1996-12-25 |
| AR245958A1 (en) | 1994-03-30 |
| ATE142696T1 (en) | 1996-09-15 |
| AU2850989A (en) | 1989-07-20 |
| FI890175A7 (en) | 1989-07-16 |
| YU6889A (en) | 1990-08-31 |
| EP0324447A3 (en) | 1990-01-31 |
| NO890174D0 (en) | 1989-01-13 |
| IE890087L (en) | 1989-07-15 |
| DK16489D0 (en) | 1989-01-13 |
| ZA89202B (en) | 1989-09-27 |
| FI890175A0 (en) | 1989-01-13 |
| GR3021887T3 (en) | 1997-03-31 |
| DE58909723D1 (en) | 1996-10-17 |
| MC2002A1 (en) | 1990-01-26 |
| JPH025892A (en) | 1990-01-10 |
| ES2091752T3 (en) | 1996-11-16 |
| PT89438A (en) | 1990-02-08 |
| IL88934A0 (en) | 1989-08-15 |
| HU208996B (en) | 1994-09-28 |
| PT89438B (en) | 1993-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ223506A (en) | Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions | |
| DK0751992T3 (en) | Karendothelial growth factor 2 | |
| ATE205254T1 (en) | TRANSFORMING GROWTH FACTOR ALPHA H1 | |
| ZA91134B (en) | New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses | |
| ATE255128T1 (en) | PEPTIDE-IMMITTING SUBSTANCES IN CANCER THERAPY | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| DE68929551D1 (en) | Human DNase | |
| AU657487B2 (en) | Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations | |
| NO177678C (en) | Method for Preparing a Therapeutically Active, Recombinant Protein having ASP Activity, Expression System, and DNA Encoding the Protein | |
| ES8306324A1 (en) | "PROCESS FOR THE MICROBIAL PRODUCTION OF HUMAN FIBROBLAST INTERFERED". | |
| RU95106651A (en) | Analogs of des-tyr-dinorphine and method of treatment of patient with tolerant states | |
| AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
| NO873699D0 (en) | POLYPEPTIDE SUITABLE FOR DIMENSION, TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES SUCH AS ARTICLES. | |
| DE3682229D1 (en) | PHARMACEUTICAL PREPARATIONS USED FOR STIMULATING TREATMENT SECRETION. | |
| NO890174L (en) | RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES. | |
| IL87391A0 (en) | Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them | |
| FI896261A7 (en) | Method for producing a protein or polypeptide, DNA sequence encoding the polypeptide, microorganism containing the DNA sequence and polypeptide and its use as a pharmaceutical preparation | |
| DK288789A (en) | PEPTIDES AND ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE | |
| ZA904565B (en) | Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection | |
| LV11803A (en) | Non-flowing gp350 / 220 variants | |
| AU2459188A (en) | Anticoagulative protein pp4-x, and its preparation and use | |
| SG128403A1 (en) | Tnf-receptors, tnf binding proteins and dnas coding for them | |
| FR2636953A1 (en) | NOVEL POLYPEPTIDES PRODUCED BY HUMAN LYMPHOCYTES, GENES ENCODING THESE POLYPEPTIDES AND PHARMACEUTICAL AND BIOLOGICAL APPLICATIONS | |
| ATE6639T1 (en) | A PURIFIED POLYPEPTIDE, PROCESS FOR ITS MANUFACTURE, ITS USE AND THE CONTAINING PHARMACEUTICAL PREPARATION. | |
| DK575287D0 (en) | USE OF TISSUE FACTOR PROTEIN AND ANTAGONISTS THEREOF FOR THE MANUFACTURE OF MEDICINAL PRODUCTS FOR THE TREATMENT OF BLEEDING ANIMALS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE |